Transcutaneous Electrical Nerve Stimulation Post-thoracic Surgery in a Intensive Care Unit

NCT ID: NCT02438241

Last Updated: 2015-05-12

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: PHASE1/PHASE2
• Total Enrollment: 45 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2015-04-30
• Study Completion Date: 2016-06-30

Brief Summary

Introduction: Pain is an important factor of increase of morbidity and mortality in patients undergoing surgical procedures include thoracotomy. There are different methods of analgesia in postoperative thoracic surgery, ranging from systemic analgesia with opioids, as well as local anesthetics block (intrapleural, extrapleural, intercostal cryoanalgesia, etc.) in addition to spinal blocks and Epidural blocks. In the pharmacological analgesia, electroanalgesia has been proposed as an adjunctive treatment for the relief of postoperative pain. Rationale: noting the lack of data in the literature regarding the use of this physical therapy technique in order to reduce the pain in the postoperative period of thoracic surgery and its consequences, it is relevant to the realization of a new randomized controlled trial (RCT) to evaluate the effects of transcutaneous electrical nerve (TENS) in the post - thoracic surgery on pain, pulmonary function and strength respiratory muscle. Objective: To evaluate the effects of TENS on pain, respiratory muscle strength and lung function in postoperative thoracic surgery in a Intensive Care Unit. Method: The subjects included will be randomized into three groups randomly: control group (CG) that will hold only conventional physical therapy, TENS group (EG) that will hold the application of TENS associated with conventional physical therapy, TENS placebo group (GP) who will perform the application of TENS placebo to conventional therapy. All groups carry out the assessments (digital manometer, spirometry, visual analog pain scale) in the preoperative period, postoperative Immediate / pre-intervention and at the end of treatment (discharge from the intensive care unit), except for the pain that will be evaluated before and after each intervention session. All patients receive physical therapy three times a day (morning, afternoon and evening) during hospitalization in the intensive care unit. Intervention: The conventional group will receive conventional therapy for hospital service. The TENS group will receive conventional therapy and the end of that service, will be applied TENS for 30 minutes. The placebo TENS group will receive the conventional physical therapy and the end of the service will be installed TENS placebo, during this period the patient receives electrical stimulation for 45 seconds, shutting down at the end of this time and held position as TENS group.

Detailed Description

An evaluation of the patient will be held in the preoperative through a standardized form containing all personal data and information regarding the history and physical examination. At this time, the patient, after reading and removal of doubts, or his guardian sign the Informed Consent making clear consent to participate. After the arrival of the surgical patient will evaluate eligibility criteria. Subjects included will be randomized into three groups randomly: control group (CG) that will hold only conventional physical therapy, TENS group (EG) that will hold the application of TENS associated with conventional physical therapy, TENS placebo group (GP) that will hold the application TENS placebo to conventional therapy. All groups carry out the assessments described below in the preoperative period, in the immediate post-operative / pre-intervention (up to 6 hours after arrival in the intensive care unit) and the end of treatment (discharge from the intensive care unit), except for the pain that will be evaluated before and after each intervention session. All patients receive physical therapy three times a day (morning, afternoon and evening) during their stay in the intensive care unit. Pain assessment: To measure the painful sensation, visual analogue scale pain will be used. Evaluation of lung function: Pulmonary function is assessed by spirometry with a portable digital spirometer Sibelmed brand, Datospir micro c model, with the objective of obtaining the lung volume and capacity. The patient is positioned in the bed (head elevated at 90º, extended legs, nasal clips in the patient (ensures optimal sealing), is positioned in the mouth patient requested a maximal inspiration followed by a maximum and sustained expiration through the mouth. During exhalation the patient will be encouraged verbally to achieve your best performance. As recommended by the American Thoracic Society and European Respiratory Society and based on the reproducibility and eligibility criteria, three maneuvers will be performed (variability of 0.150L) and considered the best curve for study. They will be obtained the forced vital capacity values (FVC), forced expiratory volume in one second (FEV1), FEV1 / FVC, peak expiratory flow and forced expiratory flow between 25 and 75% of FVC curve. The values will be recorded in absolute units of measurement and percentage of predicted. Due to the high variability between operators, this evaluation will be performed by the same researcher. Evaluation of respiratory muscle strength: To evaluate the inspiratory and expiratory muscle strength will be used, respectively, measurements of maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) through a digital manometer Globalmed make, model MVD300. The patient is positioned in the bed (headboard raised to 90 °), extended legs and a nose clip. The test is repeated 6 times with one-minute interval between each attempt, is considered the highest value since there is no difference greater than 10% between the two highest values. The MIP will be determined, based on the residual volume, the deep breath against the occluded circuit and the MEP will be obtained, starting from the total lung capacity, the expiration forced against the machine's nozzle. For analysis of the results will be considered absolute and in percentage of predicted by the equations proposed by Neder et al. Assessing the amount of medication administered: Patients from surgery can come with two types of fixed analgesia: epidural catheter or paravertebral catheter. These catheters can come up with: bupivacaine fentanyl; ropivacaine fentanyl. In addition the catheters are prescribed acetaminophen, dipyrone, tramadol, morphine. The type of fixing is controlled analgesia, dosage and dosage for each investigator assessment, furthermore all be checked to check prescriptions adjunct administered throughout the day.

Interventions TENS group: Patients randomized to this group will receive conventional physical therapy for the control group, and the end of that service, will be applied TENS. TENS is accomplished through the use of an electrical stimulation device with symmetrical biphasic current pulse. The following parameters are used: frequency: 100 Hz, pulse width: 100 µs, intensity to the greatest sensory threshold of the patient and total session time: 30 minutes. Self-adhesive electrodes will be used (Valutrode, size 5x9 cm) to be positioned in the posterolateral portion of the chest to 2 cm skin incision both upper and lower.

Placebo TENS group: Will be held the same procedure as TENS group, except that TENS will be offered to the patient only for 45 seconds, and in the first 30 seconds is reached the sensory threshold of the patient and in the last 15 seconds will turn off the electrical current by 29 remaining period minutes and 15 seconds off.

Control group: Patients randomized to this group will receive only conventional physiotherapy. The treatment protocol will consist of weathered active exercises to manually lower limbs in bed (triple flexion, abduction and adduction, plantar / dorsiflexion), free active exercises of the upper limbs in the bed (shoulder flexion, shoulder flexion and horizontal functional diagonal shoulder), bronchial hygiene techniques, flow redirection, positive expiratory pressure and ventilatory blowing patterns.

Conditions

Thoracic Surgery

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Study Groups

Conventional physiotherapy Group

Patients randomized to this group will receive only conventional physiotherapy. The treatment protocol will consist of weathered active exercises to manually lower limbs in bed (triple flexion, abduction and adduction, plantar / dorsiflexion), free active exercises of the upper limbs in the bed (shoulder flexion, shoulder flexion and horizontal functional diagonal shoulder), bronchial hygiene techniques, flow redirection, positive expiratory pressure and ventilatory blowing patterns.

Group Type: ACTIVE_COMPARATOR

Conventional physiotherapy Group

Intervention Type: PROCEDURE

Patients randomized to this group will receive only conventional physiotherapy. The treatment protocol Control Group, will consist of weathered active exercises to manually lower limbs in bed (triple flexion, abduction and adduction, plantar / dorsiflexion), free active exercises of the upper limbs in the bed (shoulder flexion, shoulder flexion and horizontal functional diagonal shoulder), bronchial hygiene techniques, flow redirection, positive expiratory pressure and ventilatory blowing patterns.

Placebo TENS Group

Will be held the same procedure as TENS group, except that TENS will be offered to the patient only for 45 seconds, and in the first 30 seconds is reached the sensory threshold of the patient and in the last 15 seconds will turn off the electrical current by 29 remaining period minutes and 15 seconds off.

Group Type: PLACEBO_COMPARATOR

Placebo TENS group

Intervention Type: PROCEDURE

Patients randomized to this group will receive conventional physical therapy (the treatment protocol Control Group), will be held the same procedure as TENS group, except that TENS will be offered to the patient only for 45 seconds, and in the first 30 seconds is reached the sensory threshold of the patient and in the last 15 seconds will turn off the electrical current by 29 remaining period minutes and 15 seconds off.

TENS group

Patients randomized to this group will receive conventional physical therapy for the control group, and the end of that service, will be applied TENS. TENS is accomplished through the use of an electrical stimulation device with symmetrical biphasic current pulse. The following parameters are used: frequency: 100 Hz, pulse width: 100 µs, intensity to the greatest sensory threshold of the patient and total session time: 30 minutes. Self-adhesive electrodes will be used (Valutrode, size 5x9 cm) to be positioned in the posterolateral portion of the chest to 2 cm skin incision both upper and lower.

Group Type: EXPERIMENTAL

TENS Group

Intervention Type: PROCEDURE

Patients randomized to this group will receive conventional physical therapy (the treatment protocol Control Group), and the end of that service, will be applied TENS. TENS is accomplished through the use of an electrical stimulation device with symmetrical biphasic current pulse. The following parameters are used: frequency: 100 Hz, pulse width: 100 µs, intensity to the greatest sensory threshold of the patient and total session time: 30 minutes. Self-adhesive electrodes will be used (Valutrode, size 5x9 cm) to be positioned in the posterolateral portion of the chest to 2 cm skin incision both upper and lower.

Interventions

Conventional physiotherapy Group

Patients randomized to this group will receive only conventional physiotherapy. The treatment protocol Control Group, will consist of weathered active exercises to manually lower limbs in bed (triple flexion, abduction and adduction, plantar / dorsiflexion), free active exercises of the upper limbs in the bed (shoulder flexion, shoulder flexion and horizontal functional diagonal shoulder), bronchial hygiene techniques, flow redirection, positive expiratory pressure and ventilatory blowing patterns.

Intervention Type: PROCEDURE

TENS Group

Patients randomized to this group will receive conventional physical therapy (the treatment protocol Control Group), and the end of that service, will be applied TENS. TENS is accomplished through the use of an electrical stimulation device with symmetrical biphasic current pulse. The following parameters are used: frequency: 100 Hz, pulse width: 100 µs, intensity to the greatest sensory threshold of the patient and total session time: 30 minutes. Self-adhesive electrodes will be used (Valutrode, size 5x9 cm) to be positioned in the posterolateral portion of the chest to 2 cm skin incision both upper and lower.

Intervention Type: PROCEDURE

Placebo TENS group

Patients randomized to this group will receive conventional physical therapy (the treatment protocol Control Group), will be held the same procedure as TENS group, except that TENS will be offered to the patient only for 45 seconds, and in the first 30 seconds is reached the sensory threshold of the patient and in the last 15 seconds will turn off the electrical current by 29 remaining period minutes and 15 seconds off.

Intervention Type: PROCEDURE

Eligibility Criteria

Inclusion Criteria

• Will be included patients between 30 and 75 years;
• Both sexes;
• Post-thoracic surgery with posterolateral thoracotomy incision for pulmonary resection (Bullectomy, segmentectomy, lobectomy, pneumonectomy);
• Evaluated between 4-6 hours after entry into the intensive care unit;
• Hemodynamic stability (mean arterial pressure between 60 mmHg and 100 mmHg, heart rate between 50 bpm and 110 bpm, peripheral saturation greater than 90%);
• Patients who have liquid drainage chest tubes in less than 300 ml for six hours;
• Scale agitation-sedation Richmond (RASS) between -1 and +1;
• Prescription physical therapy;
• Have epidural or Paravertebral catheter;
• Agree to participate in the study by signing the Informed Consent and Informed (IC ).

Exclusion Criteria

• Not intubated with up to 6 hours in the immediate postoperative period;
• Primary pulmonary disease not rise (cardiovascular, neurological diseases);
• Hemodynamic instability (with pressure mean blood less than 60 mmHg or greater 100 mmHg, heart rate less than 49 bpm and greater than 111 bpm, reduced peripheral saturation of 90%);
• Patients who have the upper drainage liquid drains to 300 ml for six hours;
• Scale agitation-sedation Richmond (RASS) between -5 and -2, and agitated / aggressive patients, scale agitation-sedation Richmond RASS +2 and +4;
• Prescribing physical therapy;
• Without epidural or paravertebral catheter;
• Patients who do not accept the study, not collaborative and do not sign the informed consent form.

• Minimum Eligible Age: 30 Years
• Maximum Eligible Age: 75 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Irmandade Santa Casa de Misericórdia de Porto Alegre

OTHER

Sponsor Role: lead

Responsible Party

Hermann Heinrich Husch

Physiotherapist intensive care unit

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Graciele Sbruzzi, doctor

Role: STUDY_DIRECTOR

Federal University of Rio Grande do Sul

Locations

Irmandade Santa Casa de Misericórdia

Porto Alegre, Rio Grande do Sul, Brazil

Countries

Brazil

References

Landreneau RJ, Pigula F, Luketich JD, Keenan RJ, Bartley S, Fetterman LS, Bowers CM, Weyant RJ, Ferson PF. Acute and chronic morbidity differences between muscle-sparing and standard lateral thoracotomies. J Thorac Cardiovasc Surg. 1996 Nov;112(5):1346-50; discussion 1350-1. doi: 10.1016/S0022-5223(96)70150-2.

Reference Type: RESULT

PMID: 8911333 (View on PubMed)

Savage C, McQuitty C, Wang D, Zwischenberger JB. Postthoracotomy pain management. Chest Surg Clin N Am. 2002 May;12(2):251-63. doi: 10.1016/s1052-3359(02)00011-x.

Reference Type: RESULT

PMID: 12122825 (View on PubMed)

Kavanagh BP, Katz J, Sandler AN. Pain control after thoracic surgery. A review of current techniques. Anesthesiology. 1994 Sep;81(3):737-59. doi: 10.1097/00000542-199409000-00028. No abstract available.

Reference Type: RESULT

PMID: 8092520 (View on PubMed)

Boisseau N, Rabary O, Padovani B, Staccini P, Mouroux J, Grimaud D, Raucoules-Aime M. Improvement of 'dynamic analgesia' does not decrease atelectasis after thoracotomy. Br J Anaesth. 2001 Oct;87(4):564-9. doi: 10.1093/bja/87.4.564.

Reference Type: RESULT

PMID: 11878725 (View on PubMed)

Benedetti F, Amanzio M, Casadio C, Cavallo A, Cianci R, Giobbe R, Mancuso M, Ruffini E, Maggi G. Control of postoperative pain by transcutaneous electrical nerve stimulation after thoracic operations. Ann Thorac Surg. 1997 Mar;63(3):773-6. doi: 10.1016/s0003-4975(96)01249-0.

Reference Type: RESULT

PMID: 9066400 (View on PubMed)

Yegin A, Erdogan A, Kayacan N, Karsli B. Early postoperative pain management after thoracic surgery; pre- and postoperative versus postoperative epidural analgesia: a randomised study. Eur J Cardiothorac Surg. 2003 Sep;24(3):420-4. doi: 10.1016/s1010-7940(03)00345-2.

Reference Type: RESULT

PMID: 12965314 (View on PubMed)

Grant RP. Con: every postthoracotomy patient does not deserve thoracic epidural analgesia. J Cardiothorac Vasc Anesth. 1999 Jun;13(3):355-7. doi: 10.1016/s1053-0770(99)90277-x. No abstract available.

Reference Type: RESULT

PMID: 10392691 (View on PubMed)

Baidya DK, Khanna P, Maitra S. Analgesic efficacy and safety of thoracic paravertebral and epidural analgesia for thoracic surgery: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg. 2014 May;18(5):626-35. doi: 10.1093/icvts/ivt551. Epub 2014 Jan 31.

Reference Type: RESULT

PMID: 24488821 (View on PubMed)

Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965 Nov 19;150(3699):971-9. doi: 10.1126/science.150.3699.971. No abstract available.

Reference Type: RESULT

PMID: 5320816 (View on PubMed)

Chandra A, Banavaliker JN, Das PK, Hasti S. Use of transcutaneous electrical nerve stimulation as an adjunctive to epidural analgesia in the management of acute thoracotomy pain. Indian J Anaesth. 2010 Mar;54(2):116-20. doi: 10.4103/0019-5049.63648.

Reference Type: RESULT

PMID: 20661348 (View on PubMed)

Erdogan M, Erdogan A, Erbil N, Karakaya HK, Demircan A. Prospective, Randomized, Placebo-controlled Study of the Effect of TENS on postthoracotomy pain and pulmonary function. World J Surg. 2005 Dec;29(12):1563-70. doi: 10.1007/s00268-005-7934-6.

Reference Type: RESULT

PMID: 16331341 (View on PubMed)

Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005 Aug;26(2):319-38. doi: 10.1183/09031936.05.00034805. No abstract available.

Reference Type: RESULT

PMID: 16055882 (View on PubMed)

Neder JA, Andreoni S, Lerario MC, Nery LE. Reference values for lung function tests. II. Maximal respiratory pressures and voluntary ventilation. Braz J Med Biol Res. 1999 Jun;32(6):719-27. doi: 10.1590/s0100-879x1999000600007.

Reference Type: RESULT

PMID: 10412550 (View on PubMed)

Husch HH, Watte G, Zanon M, Pacini GS, Birriel D, Carvalho PL, Kessler A, Sbruzzi G. Effects of Transcutaneous Electrical Nerve Stimulation on Pain, Pulmonary Function, and Respiratory Muscle Strength After Posterolateral Thoracotomy: A Randomized Controlled Trial. Lung. 2020 Apr;198(2):345-353. doi: 10.1007/s00408-020-00335-4. Epub 2020 Feb 8.

Reference Type: DERIVED

PMID: 32036406 (View on PubMed)

Related Links

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382012000100012

Estimulação elétrica nervosa transcutânea no pós-operatório de cirurgia torácica: revisão sistemática e metanálise de estudos randomizados

Other Identifiers

36851514.6.0000.5335

Identifier Type: -

Identifier Source: org_study_id